Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
about
An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCsCardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem CellsUnderstanding the genetic and molecular pathogenesis of Friedreich's ataxia through animal and cellular modelsUtility of Induced Pluripotent Stem Cells for the Study and Treatment of Genetic Diseases: Focus on Childhood Neurological DisordersInduced pluripotent stem cell potential in medicine, specifically focused on reproductive medicineModelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytesGeneration and characterisation of Friedreich ataxia YG8R mouse fibroblast and neural stem cell modelsRho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acidNeurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.Trichostatin A enhances differentiation of human induced pluripotent stem cells to cardiogenic cells for cardiac tissue engineeringFriedreich's ataxia induced pluripotent stem cell-derived cardiomyocytes display electrophysiological abnormalities and calcium handling deficiency.Functional characterization of Friedreich ataxia iPS-derived neuronal progenitors and their integration in the adult brain.Genetic variations creating microRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia.Stem cells on the brain: modeling neurodevelopmental and neurodegenerative diseases using human induced pluripotent stem cells.Probing disorders of the nervous system using reprogramming approaches.The current status of iPS cells in cardiac research and their potential for tissue engineering and regenerative medicine.Generation of disease-specific induced pluripotent stem cells from patients with different karyotypes of Down syndrome.Induced pluripotent stem cells to model and treat neurogenetic disordersHuman pluripotent stem cells: applications and challenges in neurological diseases.Role of mismatch repair enzymes in GAA·TTC triplet-repeat expansion in Friedreich ataxia induced pluripotent stem cells.New lessons learned from disease modeling with induced pluripotent stem cells.Generation of human-induced pluripotent stem cells to model spinocerebellar ataxia type 2 in vitro.Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stressStem cell technology for the study and treatment of motor neuron diseases.Human pluripotent stem cells for disease modelling and drug screening.Current status of drug screening and disease modelling in human pluripotent stem cells.Expanded complexity of unstable repeat diseases.Animal and cellular models of Friedreich ataxia.Diabetes in Friedreich ataxia.Human stem cell models of neurodegeneration: a novel approach to study mechanisms of disease development.Induced pluripotent stem cells for modeling of pediatric neurological disorders.Induced pluripotent stem cells for regenerative medicineNeural crest cells: from developmental biology to clinical interventions.Stem cell reprogramming: basic implications and future perspective for movement disorders.NEW DIRECTIONS IN BASIC RESEARCH IN HYPERTROPHY AND HEART FAILURE: RELEVANCE FOR PEDIATRIC CARDIOLOGY.Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as a Model for Heart Development and Congenital Heart Disease.Induced pluripotent stem cell technology for modelling and therapy of cerebellar ataxia.Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases?Modeling simple repeat expansion diseases with iPSC technology.Unveiling a common mechanism of apoptosis in β-cells and neurons in Friedreich's ataxia.
P2860
Q26775122-B515600B-71F1-4E24-9084-55C8E8AF7BC0Q26798131-317538F6-A7FC-46E0-AE36-7169FABA6F87Q26860523-C7E009BA-600B-484E-8B14-5FAF8DB7C384Q28080219-43475C6E-EF81-419F-BB35-C02345728DFCQ28083057-72FC6C2A-736B-4E5F-A6AB-372B82ECEC7FQ28255887-E0B14DE4-20EB-43C0-9AA3-5D194A756923Q28540063-FA90DE01-5D61-407E-BFBC-75CB7B538A41Q30538666-E3DDCC9D-B62C-472C-A253-CC48F5980F4AQ30539140-F8BB32ED-05EF-4FA3-8E86-55B053CE82A8Q30543752-A359F25F-8730-4C51-86E5-63746861584AQ33804613-BBFEA6CA-039A-4280-8F94-2C8FF947CD58Q33856264-BF7E7B77-DBD4-445A-B687-A69F41E997A8Q34575677-BA53EE48-53D8-4A84-ABAD-2E3EDB1430C0Q34845881-C5232F49-BF47-4E0F-9F17-9CC3336A12D4Q35761135-768B8C77-3F7D-498D-8E78-F5CB6D4033DBQ35765543-55485C19-2D69-488D-B63A-AC16669F6543Q36084840-6455EA33-9F2C-4768-9ABF-5619AA289B14Q36131883-13DAB018-A8EC-42A8-B752-507BB0F885AFQ36193696-7D6F4ACF-074F-4463-9B38-5ED9E5E83DDAQ36216018-01011CEB-AA32-4D43-B482-61BB91582775Q36374130-DF392DD5-0E7E-46B7-A10A-B52EB69DDECAQ36717931-91100AF5-BE54-41E1-9703-DF943D4B03D6Q37052023-3B975B2F-887B-43B3-9284-CDEB1441BD7CQ37851503-91235934-2EAE-4B55-A53C-58197C40BFF8Q37950950-4FA5C488-B61F-45EE-8FB6-9033ED9E0BDBQ38034129-05396304-1939-4EFB-AF96-DEA14E68B792Q38066802-88FB0BCF-03D1-44F3-A4C9-E0E5B06F52E7Q38121944-96A97F36-08C8-4E54-9E54-CF575559C12AQ38121947-D670FEFB-CA9E-4C1D-8BC7-8D9243522A64Q38168763-49A78AD3-1601-4EEA-A983-DB63450ED828Q38212628-914A00BC-A943-46AF-88DE-CF2014CE39D4Q38218254-01FADC05-C0AF-49EC-84B3-FC1A8FB81390Q38250145-956205E4-6ED9-41F3-B180-768EF9966EDDQ38302834-B838A72C-F1C6-437A-B1FC-E7A46DE50216Q38384661-7A53A6D6-38F5-4E26-8094-BD8BB6598DCAQ38530607-DEC007AA-7036-4DCE-A06C-6DE1240D1170Q38542017-B2A2CBCD-3AD8-40D1-A89E-232932C5AE41Q38739919-8B3D8F84-A695-4F6C-AE0C-0BA74CEB8F82Q38853911-B5D8F1D1-B104-4BDD-9C02-57CFFC10AABCQ38924043-7A48A43D-53F8-43C9-BE92-03C22DF8B197
P2860
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
@en
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
@nl
type
label
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
@en
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
@nl
prefLabel
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
@en
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.
@nl
P2093
P2860
P50
P1476
Generation of induced pluripotent stem cell lines from Friedreich ataxia patients
@en
P2093
Anna Michalska
Jessie Leung
Joseph P Sarsero
Marguerite V Evans-Galea
Martin B Delatycki
Paul J Verma
Robert Williamson
P2860
P2888
P304
P356
10.1007/S12015-010-9210-X
P577
2011-09-01T00:00:00Z